US Hospitals Will Restrict Lilly COVID-19 Antibody Treatment

US hospitals said on Tuesday they may limit the use of the new Eli Lilly antibody drug to COVID-19 patients with multiple risk factors for serious illness or to those patients whose immune systems have not begun to fight the infection.

Read more